A 25-year-old man presents to the clinic for a routine health maintenance examination. He has no past medical history and takes no medications. The patient reports having unprotected receptive anal intercourse with a new male partner 4 weeks ago. He is currently asymptomatic. Physical examination reveals normal vital signs and no lymphadenopathy, rash, or mucosal lesions. The patient requests screening for sexually transmitted infections, including HIV.
Arrange the following steps in the most appropriate chronological order for the diagnosis and initial management of this patient's suspected HIV infection, in accordance with current guidelines.
- 1Perform an initial screening using a fourth-generation HIV-1/2 antigen/antibody combination immunoassay.
- 2Perform an HIV-1/HIV-2 antibody differentiation immunoassay to confirm the diagnosis.
- 3Obtain baseline blood samples for CD4 cell count, HIV RNA viral load, and genotypic resistance testing.
- 4Initiate empiric combination antiretroviral therapy (cART) without awaiting resistance testing results.
Answer
The correct chronological sequence is: 1) Initial screening with the 4th-generation HIV-1/2 antigen/antibody combination immunoassay, 2) Confirmation with the HIV-1/HIV-2 antibody differentiation immunoassay, 3) Obtaining baseline blood samples for CD4, viral load, and genotypic resistance testing, and 4) Initiating empiric combination antiretroviral therapy (cART).
The correct sequence follows the current CDC guidelines for HIV diagnosis and the principles of rapid antiretroviral therapy initiation. The diagnostic algorithm always begins with a highly sensitive fourth-generation HIV-1/2 antigen/antibody combination immunoassay. A reactive result must be confirmed with an HIV-1/HIV-2 antibody differentiation immunoassay, which establishes the diagnosis and distinguishes the viral type. Once HIV is confirmed, the standard of care is to initiate combination antiretroviral therapy (cART) as rapidly as possible, often on the same day. However, it is absolutely critical to obtain blood samples for baseline HIV RNA viral load, CD4 cell count, and genotypic resistance testing prior to administering the first dose of cART. If cART is administered before these labs are drawn, the resulting viral suppression can make it impossible to amplify the virus for resistance testing. Conversely, clinicians should not delay cART initiation while awaiting the results of the resistance testing; an empiric regimen is started immediately and adjusted later if necessary.
Step-by-Step Solution
Key Concept
The CDC HIV diagnostic algorithm and the principles of rapid antiretroviral therapy initiation.
Estimated Time:1m 30s